Does Alexion Pharmaceuticals, Inc. sponsor H-1B?
Yes. Alexion Pharmaceuticals, Inc. filed H-1B LCAs covering 9 positions in fiscal year 2026.
Alexion Pharmaceuticals, Inc. filed E-3 LCAs covering 1 position in fiscal year 2021.
Hiring Trends
H-1B Salary Data
| Visa type | New Hires | Min | P25 | Median salary | P75 | Max |
|---|---|---|---|---|---|---|
| H-1B | 3 | $106,605 | $124,685 | $142,766 | $151,042 | $159,318 |
Job Titles
| Job Title Filed↕ | SOC↕ | Positions↓ | Median↕ | Mean↕ |
|---|---|---|---|---|
| Associate Director, Commercial Data Analytics and Reporting | 15-1243.00 · Database Architects | 1 | $201k | $201k |
| Associate Director, Commercial Data Analytics and Reporting | 15-2051.01 · Business Intelligence Analyst | 1 | $162k | $162k |
| Associate Director, Data Operations & Data Quality | 15-1242.00 · Database Administrator | 1 | $178k | $178k |
| Associate Director, Research Collaborations and Alliances | 13-1082.00 · Project Management Specialists | 1 | $170k | $170k |
| Global/US Market Research & CI Partner | 13-1161.00 · Market Research Analysts and Marketing Specialists | 1 | $167k | $167k |
| Manager, Biostatistics | 15-2041.01 · Biostatisticians | 1 | $159k | $159k |
| PDCS Compliance Specialist | 11-9199.02 · Compliance Managers | 1 | $107k | $107k |
| Scientist II, Injectable Drug Product Development | 19-1042.00 · Medical Scientists, Except Epidemiologists and Advisors | 1 | $143k | $143k |
| Sr. Mgr., Global Med Affairs Business Ops Partner | 11-9121.00 · Natural Sciences Managers | 1 | $166k | $166k |
H-1B Filings
Work Locations
| City | State | LCA filings |
|---|---|---|
| Boston | MA | 5 |
| New Haven | CT | 4 |
No F-1 employer data is available for this employer. ICE publishes OPT, STEM OPT, and CPT figures once a year, and not every year has been released.
Data Sources
- The Department of Labor releases LCA disclosure data quarterly. Figures on this page reflect filings through FY2026 Q2.
- ICE provides OPT, STEM OPT, and CPT employer data once a year, and not every year has been released. The most recent report covers 2024.